Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


"Deceptive" weight-loss marketers pay up

This article was originally published in The Tan Sheet

Executive Summary

A federal district court orders Bronson Partners and its officer, Martin Howard, to pay the Federal Trade Commission nearly $2 million for making deceptive claims that its Chinese Diet Tea and Bio-Slim Patch products allow users to lose weight quickly without diet or exercise, FTC announces Jan. 11. Additionally, the U.S. District Court for the District of Connecticut granted the commission's request to prohibit the defendants from deceptively selling or advertising any weight-loss products, and ordered the firm to help FTC identify consumers who lost money on the products. Ads claimed the tea could "neutralize the absorption of fattening foods" and said "repulsive, excess ugly fatty tissue will disappear" by using the patch. The FTC filed its complaint against Bronson as part of its "Big Fat Lie" law enforcement sweep in 2004 (1"The Tan Sheet" Nov. 15, 2004)

You may also be interested in...

“Operation Big Fat Lie”: FTC Files Suits, Fights Bogus Weight-Loss Ads

FTC's "Red Flag" initiative has roughly halved the number of ads with fraudulent weight-loss claims since its inception, according to the commission

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza

The latest drug development news and highlights from our US FDA Performance Tracker.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts